Follow the 이오플로우 share price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 이오플로우 has logged 6 insider filings. Market capitalisation: €62bn. The latest transaction was disclosed on 27 April 2026 (Purchase). Among the most active insiders: 이오플로우. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
이오플로우是一家在XKRX市场上市的医疗保健和制药公司。该公司专注于开发糖尿病管理的创新解决方案。